RECEIVING IMMUNOTHERAPY EARLIER IN THE DAY MAY IMPROVE SURVIVAL IN CANCER PATIENTS
Receiving anticancer immunotherapy earlier in the day may help individuals with cancer live longer. That's according to a study published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society.
An internal clock, or circadian rhythm, affects when different physiological processes (including immune reactions) in the body are active. This might explain why various medications appear to be more effective when taken at certain times of day.
Researchers investigated this phenomenon in 397 patients with extensive-stage small cell lung cancer who received the immunotherapy drugs atezolizumab or durvalumab plus chemotherapy at the Affiliated Cancer Hospital of Xiangya School of Medicine at Central South University, in China, between May 2019 and October 2023.
2025-12-08T14:18:18Z